Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis

The Lancet Infectious Diseases - Tập 18 Số 3 - Trang 318-327 - 2018
Evelina Tacconelli1,2, Elena Carrara1,2, Alessia Savoldi1, Stephan Harbarth3, Marc Mendelson4, Dominique L Monnet5, Céline Pulcini6, Gunnar Kahlmeter7, Jan Kluytmans8,9, Yehuda Carmeli10, Marc Ouellette11, Kevin Outterson12, Jean B. Patel13, Marco Cavaleri14, Edward Cox15, Chris R Houchens16, M Lindsay Grayson17, Paul Hansen18, Nalini Singh19, Ursula Theuretzbacher20, Nicola Magrini21, Aaron O. Aboderin, Seif Al-Abri, Nordiah Awang Jalil, Nur Benzonana, Sanjay Bhattacharya, Adrian Brink, Francesco Burkert, Otto Cars, Giuseppe Cornaglia, Oliver J. Dyar, Alexander W. Friedrich, Ana Cristina Gales, Sumanth Gandra, Christian G. Giske, Debra A. Goff, Herman Goossens, Thomas Gottlieb, Manuel Guzmán Blanco, Waleria Hryniewicz, Deepthi Kattula, Timothy M. Jinks, Souha S. Kanj, L D Kerr, Marie-Paule Kiény, Yang Soo Kim, Roman Kozlov, Jaime Labarca, Ramanan Laxminarayan, Karin Leder, Leonard Leibovici, Carlos F. Amábile-Cuevas, Jasper Littman, Surbhi Malhotra‐Kumar, Vikas Manchanda, Lorenzo Moja, B Ndoye, Angelo Pan, David L. Paterson, Mical Paul18, Haibo Qiu, Pilar Ramón-Pardo, Jesús Rodríguez‐Baño, Maurizio Sanguinetti, Sharmila Sengupta, Mike Sharland, Massinissa Si-Mehand, Lynn L. Silver, Wonkeung Song, Martin Steinbakk, Jens Thomsen, Guy Thwaites, J W van der Meer, H. Rogier van Doorn, Silvio Vega, María Virginia Villegas, Agnes Wechsler-Fördös, Heiman Wertheim, Evelyn Wesangula, Neil Woodford, Fidan O Yilmaz, Anna Zorzet
1German Centre for Infection Research, Tübingen University Hospital, Tübingen, Germany
2Verona University Hospital, Verona, Italy
3World Health Organization Collaborating Centre on Patient Safety, Geneva University Hospitals and Faculty of Medicine, Geneva, Switzerland
4Groote Schuur Hospital, University of Cape Town, Cape Town, South Africa
5European Centre for Disease Prevention and Control, Stockholm, Sweden
6EA 4360 APEMAC, Nancy University Hospital, Lorraine University, Nancy, France
7Central Hospital,Växjö, Sweden
8Amphia Hospital, Breda, Netherlands
9University Medical Center Utrecht, Netherlands
10Laboratory for Microbiology and Infection Control, Tel Aviv University, Tel Aviv, Israel
11Laval University and Canadian Institutes for Health Research, Québec, QC, Canada
12Combating Antibiotic Resistant Bacteria Biopharmaceutical Accelerator CARB-X, Boston University, Boston, MA, USA
13Centers for Disease Control and Prevention, Atlanta, GA USA
14European Medicines Agency, London, UK
15US Food and Drug Administration, Washington, DC, USA
16Antibacterials Program Biomedical Advanced Research and Development Authority, Washington, DC, USA
17Austin Health, University of Melbourne, Melbourne, Vic., Australia
18Department of Infectious Diseases and Microbiology, University of Otago, Dunedin, New Zealand
19Children's National Health System, George Washington University, Washington, DC, USA
20Center for Anti-Infective Agents, Vienna, Austria
21Essential Medicines and Health Products, World Health Organization, Geneva, Switzerland

Tóm tắt

Từ khóa


Tài liệu tham khảo

2014

2016

Luepke, 2017, Past, present, and future of antibacterial economics: increasing bacterial resistance, limited antibiotic pipeline, and societal implications, Pharmacother, 37, 71, 10.1002/phar.1868

Jensen, 2010, Effect of generics on price and consumption of ciprofloxacin in primary healthcare: the relationship to increasing resistance, J Antimicrob Chemother, 65, 1286, 10.1093/jac/dkq093

2001

Kostyanev, 2016, The innovative medicines initiative's new drugs for bad bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance, J Antimicrob Chemother, 71, 290, 10.1093/jac/dkv339

2015

Thokala, 2016, Multiple criteria decision analysis for health care decision making. An introduction: report 1 of the ISPOR MCDA emerging good practices task force, Value Health, 19, 1, 10.1016/j.jval.2015.12.003

Garner, 2015, An assessment of antimicrobial resistant disease threats in Canada, PLoS One, 10, e0125155, 10.1371/journal.pone.0125155

Marsh, 2016, Multiple criteria decision analysis for health care decision making—emerging good practices: report 2 of the ISPOR MCDA emerging good practices task force, Value Health, 19, 125, 10.1016/j.jval.2015.12.016

Moher, 2009, Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement, PLoS Med, 6, e1000097, 10.1371/journal.pmed.1000097

Hansen, 2008, A new method for scoring additive multi-attribute value models using pairwise rankings of alternatives, Journal of Multi-Criteria Decision Analysis, 15, 87, 10.1002/mcda.428

2017

Pumart, 2012, Health and economic impacts of antimicrobial resistance in Thailand, J Health Systems Res, 6, 352

Laxminarayan, 2016, Access to effective antimicrobials: a worldwide challenge, Lancet, 387, 168, 10.1016/S0140-6736(15)00474-2

de Kraker, 2016, Will 10 million people die a year due to antimicrobial resistance by 2050?, PLoS Med, 13, e1002184, 10.1371/journal.pmed.1002184

Pulcini, 2012, Forgotten antibiotics: an inventory in Europe, the United States, Canada, and Australia, Clin Infect Dis, 54, 268, 10.1093/cid/cir838

Pulcini, 2017, Ensuring universal access to old antibiotics: a critical but neglected priority, Clin Microbiol Infect, 10.1016/j.cmi.2017.04.026

Thông tin
Thông tin xuất bản

The Lancet Infectious Diseases

Tập 18 Số 3

318-327

Thông tin tác giả